Related Experiment Videos
Response of preterm infants to diphtheria-tetanus-pertussis immunizations
Insights
Preterm infants show strong antibody responses to diphtheria, tetanus, and pertussis (DTP) vaccines, with minimal side effects. Routine DTP immunization can begin at 2 months of age for these infants.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Preterm infants often have different immune responses compared to full-term infants.
- Establishing safe and effective vaccination schedules for preterm infants is crucial for their health.
- Diphtheria, tetanus, and pertussis (DTP) vaccination is a standard preventative measure.
Purpose of the Study:
- To assess antibody responses in preterm infants following DTP vaccination.
- To determine the safety and side effect profile of DTP vaccine in preterm infants.
- To provide evidence-based guidelines for DTP immunization in preterm infants.
Main Methods:
- Quantified DTP-specific antibody levels in 25 preterm infants before and after immunization.
- Compared antibody responses and side effects with a control group of term infants.
- Monitored clinical side effects through parental reports.
Main Results:
- 100% of preterm infants demonstrated specific antibody production against diphtheria, tetanus, and pertussis after the second DTP dose.
- The overall incidence of side effects was low in the preterm group.
- Irritability was observed more frequently in preterm infants post-immunization.
Conclusions:
- Preterm infants mount adequate antibody responses to the DTP vaccine.
- DTP vaccination is generally safe for preterm infants, with manageable side effects.
- Routine DTP immunization can be initiated at 2 months of age for preterm infants without delay.
Abstract:
To establish guidelines for the routine use of diphtheria, tetanus, and pertussis (DTP) vaccine in preterm infants, we quantitated antibody responses of preterm infants to DTP and determined the nature and extent of side effects. Twenty-five preterm infants were immunized with 0.5 ml DTP vaccine at routine intervals. Term infants served as controls. Immediately before each immunization and 2 months after the third, DTP-specific antibodies were quantitated. Clinical side effects were determined by parental report. After the second immunization, 100% of preterm infants had evidence of specific antibody production against diphtheria, tetanus, and pertussis. The incidence of side effects was low, but irritability was significantly more common in preterm infants after the second immunization. These observations suggest that the initiation of primary immunization with DTP in preterm infants need not be delayed beyond 2 months of age.